Journal of Quality and Reliability Engineering / 2013 / Article / Tab 4

Research Article

Acceptance Sampling Plans from Life Tests Based on Percentiles of Half Normal Distribution

Table 4

Minimum ratio for the acceptability of a lot with producer’s risk 0.05.

0.1 0.2 0.4 0.6 0.8 1.0 1.5 2.0 2.5 3.0

0.75 0 27.2995 27.3264 25.2820 25.3354 25.3887 31.7358 31.8683 42.4911 53.1138 32.2612
0.75 1 7.5211 7.4707 7.0638 6.9551 6.8415 7.0279 5.9340 7.9120 5.9356 7.1227
0.75 2 4.6982 4.6579 4.5740 4.4857 4.3925 4.1606 4.2240 4.2572 5.3215 4.2191
0.75 3 3.6690 3.6354 3.4860 3.5693 3.4898 3.5650 3.5335 3.0410 3.8013 3.1989
0.75 4 3.1398 3.1106 3.0490 2.9280 3.0224 2.9465 2.7276 3.0537 3.0610 2.6281
0.75 5 2.7959 2.7492 2.6938 2.6752 2.5684 2.5816 2.5929 2.5693 2.6240 2.3656
0.75 6 2.5649 2.5411 2.4575 2.4019 2.4074 2.3411 2.2305 2.2542 2.3369 2.8043
0.75 7 2.3985 2.3630 2.3429 2.2910 2.2887 2.1705 2.1968 2.3400 2.1320 2.5584
0.75 8 2.2725 2.2520 2.2076 2.1353 2.1038 2.1610 1.9808 2.1336 1.9782 2.3739
0.75 9 2.1635 2.1442 2.1022 2.0753 2.0432 2.0464 1.9775 1.9748 2.1740 2.2298
0.75 10 2.0847 2.0577 2.0176 1.9725 1.9931 1.9550 1.9712 1.8485 2.0464 2.1137

0.90 0 44.0826 44.1095 42.0653 44.2167 42.1723 42.2257 31.8683 42.4911 53.1138 63.7366
0.90 1 10.7007 10.4994 10.0945 9.6860 9.2735 10.0728 8.2474 7.9120 9.8900 7.1227
0.90 2 6.4092 6.2376 6.1553 6.0698 5.9809 5.4907 5.2368 5.6320 5.3215 6.3857
0.90 3 4.8111 4.7384 4.5906 4.5183 4.4422 4.3623 4.1426 3.8877 3.8013 4.5615
0.90 4 3.9865 3.9303 3.8153 3.7515 3.6839 3.5015 3.5805 3.6368 3.0610 3.6731
0.90 5 3.4961 3.4497 3.3544 3.2966 3.2348 3.2105 2.9167 3.0187 3.2117 3.1488
0.90 6 3.1546 3.0983 3.0488 2.9954 2.9380 2.8428 2.7494 2.6193 2.8177 2.8043
0.90 7 2.9122 2.8770 2.7767 2.6995 2.7270 2.5857 2.6252 2.6377 2.5401 2.5584
0.90 8 2.7309 2.6877 2.6215 2.5512 2.4762 2.5130 2.3481 2.3904 2.3338 2.3739
0.90 9 2.5801 2.5413 2.5003 2.4353 2.3657 2.3516 2.2950 2.2008 2.1740 2.2298
0.90 10 2.4598 2.4243 2.3678 2.3422 2.2768 2.2240 2.2503 2.2469 2.3107 2.1137

0.95 0 57.7180 56.6969 54.6527 50.5105 50.5640 52.7154 47.6037 42.4911 53.1138 63.7366
0.95 1 13.1233 12.9222 12.5182 12.4144 11.7015 11.5919 10.5419 10.9966 9.8900 11.8680
0.95 2 7.5278 7.4222 7.2090 6.8610 6.5094 6.8151 6.2408 5.6320 5.3215 6.3857
0.95 3 5.5593 5.4474 5.2215 5.2290 5.0756 4.7596 4.7466 4.7113 4.8596 4.5615
0.95 4 4.5600 4.4766 4.3623 4.2449 4.1238 4.0540 4.0012 3.6368 3.8171 3.6731
0.95 5 3.9491 3.9029 3.7669 3.6688 3.5670 3.4192 3.2373 3.4572 3.2117 3.1488
0.95 6 3.5477 3.4916 3.3770 3.2917 3.2025 3.1754 3.0050 2.9739 2.8177 2.8043
0.95 7 3.2501 3.2015 3.1018 3.0256 2.9455 2.8609 2.8366 2.6377 2.9250 3.0482
0.95 8 3.0289 2.9859 2.8972 2.8279 2.7544 2.7464 2.7084 2.6410 2.6670 2.8005
0.95 9 2.8479 2.7993 2.7389 2.6749 2.6067 2.5540 2.4517 2.4208 2.4685 2.6088
0.95 10 2.7041 2.6687 2.6127 2.5529 2.4889 2.4024 2.3882 2.2469 2.3107 2.4557

0.99 0 88.1383 86.0673 84.0232 81.9790 75.7389 73.6945 63.3385 63.4716 53.1138 63.7366
0.99 1 18.2712 17.7675 17.3645 16.9596 16.5526 16.1433 15.1091 14.0558 13.7457 11.8680
0.99 2 10.0941 9.9229 9.5790 9.2329 8.6206 8.7969 8.2360 8.3211 7.0400 8.4480
0.99 3 7.2133 7.1017 6.7979 6.6493 6.3403 6.3445 5.9462 5.5234 5.8892 5.8316
0.99 4 5.7617 5.6786 5.4559 5.2305 5.2214 4.8799 4.8365 4.7740 4.5460 4.5805
0.99 5 4.9170 4.8504 4.6741 4.5363 4.3954 4.2512 4.1877 3.8890 3.7734 3.8540
0.99 6 4.3502 4.2779 4.16472 3.9820 3.8621 3.8379 3.5116 3.6659 3.2741 3.3812
0.99 7 3.9395 3.8776 3.7517 3.6770 3.5993 3.4087 3.2557 3.2162 3.2971 3.0482
0.99 8 3.6363 3.5820 3.4483 3.3804 3.3092 3.2113 3.0646 2.8874 2.9880 3.2004
0.99 9 3.4034 3.3549 3.2557 3.1533 3.0872 3.0576 2.9161 2.8494 2.7510 2.9622
0.99 10 3.2100 3.1574 3.0673 2.9738 2.9118 2.8460 2.7972 2.6279 2.5624 2.7713

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.